What about the company Vertex didn’t buy?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hello, everyone. Damian here with what is my final edition of The Readout on my last day at STAT. I’ve had a wonderful time covering biotech here these last eight years, and that’s in no small part a testament to the clever and engaged readers of this very newsletter. Meghana Keshavan isn’t going anywhere, and starting soon you’ll be reading a new voice in your inbox. Thanks for reading, and have a great weekend.
Read Original Article: What about the company Vertex didn’t buy? »
